|
Alomone Labs
kv1 5 Kv1 5, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/kv1 5/product/Alomone Labs Average 93 stars, based on 1 article reviews
kv1 5 - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
|
TargetMol
compound 4 ![]() Compound 4, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/compound 4/product/TargetMol Average 93 stars, based on 1 article reviews
compound 4 - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
kv1 5 antibody ![]() Kv1 5 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/kv1 5 antibody/product/Santa Cruz Biotechnology Average 93 stars, based on 1 article reviews
kv1 5 antibody - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
|
Alomone Labs
swine ![]() Swine, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/swine/product/Alomone Labs Average 93 stars, based on 1 article reviews
swine - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
kv1 5 shrna human ltv particles ![]() Kv1 5 Shrna Human Ltv Particles, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/kv1 5 shrna human ltv particles/product/Santa Cruz Biotechnology Average 85 stars, based on 1 article reviews
kv1 5 shrna human ltv particles - by Bioz Stars,
2026-04
85/100 stars
|
Buy from Supplier |
|
AstraZeneca ltd
kv1.5 experiments ![]() Kv1.5 Experiments, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/kv1.5 experiments/product/AstraZeneca ltd Average 90 stars, based on 1 article reviews
kv1.5 experiments - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
IDrug GmbH
kv1.5 currents ![]() Kv1.5 Currents, supplied by IDrug GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/kv1.5 currents/product/IDrug GmbH Average 90 stars, based on 1 article reviews
kv1.5 currents - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
ImmunoWay Biotechnology Company
kv1.5 ![]() Kv1.5, supplied by ImmunoWay Biotechnology Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/kv1.5/product/ImmunoWay Biotechnology Company Average 90 stars, based on 1 article reviews
kv1.5 - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Cardiome Inc
kv1.5-specific blocker dmm ![]() Kv1.5 Specific Blocker Dmm, supplied by Cardiome Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/kv1.5-specific blocker dmm/product/Cardiome Inc Average 90 stars, based on 1 article reviews
kv1.5-specific blocker dmm - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Scientific Reports
Article Title: Design and bioactivity evaluation of a novel autotaxin inhibitor with anti-hepatic fibrosis effects
doi: 10.1038/s41598-025-95464-2
Figure Lengend Snippet: Interactions between compound 4 with ATX enzyme. The compound 4 formed four π-π and one sigma-π interactions with ATX enzyme.
Article Snippet:
Techniques:
Journal: Scientific Reports
Article Title: Design and bioactivity evaluation of a novel autotaxin inhibitor with anti-hepatic fibrosis effects
doi: 10.1038/s41598-025-95464-2
Figure Lengend Snippet: Effects of the compound 4 on liver fibrosis in vivo. Liver sections stained with Sirius red. ( A ) The normal control group. ( B ) Model group. Mice were injected intraperitoneally with 20% CCl4 in rapeseed oil (0.5 ml/100 g body weight, twice weekly) for 33 days. ( C – E ) Model mice were intraperitoneally injected with the compound 4 of low-dose group (7.5 mg/kg), middle-dose (15 mg/kg), high-dose (30 mg/kg), respectively, starting from the 14th day of the CCl4 injection for a total of 20 days. ( F ) The normal mice treated with compound 4 of high-doze group (30 mg/kg) administration. Six random microscope fields were assessed. Magnification×10.
Article Snippet:
Techniques: In Vivo, Staining, Control, Injection, Microscopy
Journal: Scientific Reports
Article Title: Design and bioactivity evaluation of a novel autotaxin inhibitor with anti-hepatic fibrosis effects
doi: 10.1038/s41598-025-95464-2
Figure Lengend Snippet: Compound 4 inhibits inflammation of liver and effects on blood glucose, blood lipid and renal function in vivo.
Article Snippet:
Techniques: Control
Journal: PLOS ONE
Article Title: Hydrogen decreases susceptibility to AngII-induced atrial fibrillation and atrial fibrosis via the NOX4/ROS/NLRP3 and TGF-β1/Smad2/3 signaling pathways
doi: 10.1371/journal.pone.0310852
Figure Lengend Snippet: (A) Western blot bands showing p-CaMKII together with p-RyR2. (B) and (C) The relative p-CaMKII and p-RyR2 protein expression. (D) Western blot bands of Kv1.5, Kir3.1 and Kir3.4. (E-G) The relative levels of Kv1.5, Kir3.1 and Kir3.4 proteins; (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 versus Con group; #P < 0.05, ##P < 0.01, ###P < 0.001, versus AngII group.
Article Snippet: Thereafter, primary antibodies, which included NOX4 (14347-1-AP, Proteintech, 1:1000), p22phox (sc-271968, Santa Cruz Biotechnology, 1:200), NLRP3 (ab214185, Abcam, 1:1000), ASC (sc-514414, Santa Cruz Biotechnology, 1:200), caspase1-p20 (22915–1-AP, Santa Cruz Biotechnology, 1:1,000), phospho-CaMKII (ab182674, Abcam, 1:1000), phospho-RyR2 (Ser2814,GTX00626, Genetex, 1:1000),
Techniques: Western Blot, Expressing
Journal: PLOS ONE
Article Title: Hydrogen decreases susceptibility to AngII-induced atrial fibrillation and atrial fibrosis via the NOX4/ROS/NLRP3 and TGF-β1/Smad2/3 signaling pathways
doi: 10.1371/journal.pone.0310852
Figure Lengend Snippet: (A) ROS production in HL-1 cells by immunofluorescence staining (×200). (B) Expression of NLRP3 within HL-1 cells by immunofluorescence staining (×200). (C) Intracellular Ca 2+ concentration in HL cells by fluorescent probes (×200). (D), (E) and (F) mRNAs of Kv1.5, Kir3.1 and Kir3.4 by qRT-PCR. (n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, versus Con group; # P < 0.05, ## P < 0.01, ### P < 0.001, versus AngII group.
Article Snippet: Thereafter, primary antibodies, which included NOX4 (14347-1-AP, Proteintech, 1:1000), p22phox (sc-271968, Santa Cruz Biotechnology, 1:200), NLRP3 (ab214185, Abcam, 1:1000), ASC (sc-514414, Santa Cruz Biotechnology, 1:200), caspase1-p20 (22915–1-AP, Santa Cruz Biotechnology, 1:1,000), phospho-CaMKII (ab182674, Abcam, 1:1000), phospho-RyR2 (Ser2814,GTX00626, Genetex, 1:1000),
Techniques: Immunofluorescence, Staining, Expressing, Concentration Assay, Quantitative RT-PCR